Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 275092
                    [Title] => Treatment of chronic hepatitis B: Who to treat, what to use, and for how long?
                    [Summary] => Chronic hepatitis B infection continues to be a major public health concern worldwide. The natural history of the disease can be divided into 4 different phases: immune tolerance, immune clearance, inactive carrier, and reactivation. The goals of treatment are sustained viral suppression, normalization of ALT, and improvement in liver histology. Antiviral agents in current use include standard interferon, lamivudine, and adefovir.
                    [DatePublished] => 2005-04-24 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

LAMIVUDINE

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 275092
                    [Title] => Treatment of chronic hepatitis B: Who to treat, what to use, and for how long?
                    [Summary] => Chronic hepatitis B infection continues to be a major public health concern worldwide. The natural history of the disease can be divided into 4 different phases: immune tolerance, immune clearance, inactive carrier, and reactivation. The goals of treatment are sustained viral suppression, normalization of ALT, and improvement in liver histology. Antiviral agents in current use include standard interferon, lamivudine, and adefovir.
                    [DatePublished] => 2005-04-24 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

abtest

Treatment of chronic hepatitis B: Who to treat, what to use, and for how long?

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | April 24, 2005 - 12:00am

Chronic hepatitis B infection continues to be a major public health concern worldwide. The natural history of the disease can be divided into 4 different phases: immune tolerance, immune clearance, inactive carrier,...

Opinion